CooperCompanies Announces Executive Management Changes
November 18 2021 - 9:00AM
CooperCompanies (NYSE: COO) today announced two senior leadership
changes that will enable the company to maximize current and future
opportunities. Effective February 1, 2022, Dan McBride, Executive
Vice President (EVP), Chief Operating Officer of CooperCompanies,
will take on additional responsibilities that span the
organization. In conjunction with this move, Jerry Warner EVP,
Americas and Global Commercial Functions of CooperVision, will be
promoted to President of CooperVision, effective February 1, 2022.
“We have a multifaceted, global organization that’s only getting
bigger and stronger,” said Al White, CooperCompanies President and
CEO. “Both our businesses – vision and women’s health – are
actively creating new categories and expanding around the world.
Dan has the experience and vision to help guide our dynamic growth,
and Jerry has the leadership strengths and industry relationships
that are critical to CooperVision’s continued success.”
In his expanded role, Mr. McBride will continue to be
responsible for CooperVision while also assuming global leadership
for human resources and legal, in addition to assuming a more
active role in corporate strategy. Mr. McBride has been with Cooper
for more than 16 years, having served as EVP, Chief Operating
Officer at CooperCompanies since 2013, and President of
CooperVision since 2014.
In his new role as President of CooperVision, Mr. Warner will
oversee all worldwide functions within the CooperVision business
unit and continue to report to Mr. McBride. Mr. Warner has
extensive experience in the vision care industry. Over the past ten
years at CooperVision, he has held a variety of marketing,
commercial and strategic leadership roles. Before joining
CooperVision in 2012, he spent 11 years at Bausch + Lomb in product
marketing and management.
About CooperCompaniesCooperCompanies ("Cooper")
is a global medical device company publicly traded on the NYSE
(NYSE: COO). Cooper operates through two business units,
CooperVision and CooperSurgical. CooperVision brings a refreshing
perspective on vision care with a commitment to developing a wide
range of high-quality products for contact lens wearers and
providing focused practitioner support. CooperSurgical is committed
to advancing the health of women, babies and families with its
diversified portfolio of products and services focusing on medical
devices and fertility & genomics. Headquartered in San Ramon,
CA, Cooper has a workforce of more than 12,000 with products sold
in over 100 countries. For more information, please visit
www.coopercos.com.
Contact:Kim DuncanVice President, Investor Relations and Risk
Management925-460-3663ir@cooperco.com
Cooper Companies (NYSE:COO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cooper Companies (NYSE:COO)
Historical Stock Chart
From Apr 2023 to Apr 2024